Answers are grounded in this paper and cite their sources.
A total of 532 type 2 diabetes mellitus patients, who started insulin treatment due to the inability to achieve glycemic control with maximum oral anti-diabetic treatment, were included in the study. The patients were divided into three groups according to their smoking status at the beginning of insulin therapy: smokers (n = 114), ex-smokers (n = 178), and non-smokers (n = 240). Demographic and metabolic data, treatment regimens, and insulin start times were evaluated.
No takes yet. Share an insight, caveat, or question.
Aydan et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: